The largest database of trusted experimental protocols

R plex human neurofilament l antibody set

Manufactured by Mesoscale

The R-PLEX human neurofilament L antibody set is a laboratory equipment product designed for the detection and quantification of neurofilament L, a structural protein found in neurons. The set includes a capture antibody and a detection antibody, which can be used in a sandwich immunoassay format to measure the levels of neurofilament L in biological samples.

Automatically generated - may contain errors

Lab products found in correlation

3 protocols using r plex human neurofilament l antibody set

1

Plasma Aβ and NfL Biomarker Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma Aβ42 and Aβ40 levels were assessed by immunoprecipitation mass spectrometry as previously described [11 ]. Aβ levels were analysed and calculated by integrated peak area ratios to known concentrations of the internal standards using the Skyline software package [12 ]. Plasma NfL levels were measured using the R-PLEX human neurofilament L antibody set (Meso Scale Discovery, F217X). Samples were diluted 2-fold in a diluent buffer and tested in duplicate according to the manufacturer’s instructions.
Plasma Aβ or NfL levels were measured once using blood samples collected in the first or second year of the study. For most participants (n = 420 out of 452), Aβ and NfL levels were measured from blood samples taken at the 1-year wave of data collection. For the rest of the participants, plasma markers were measured using samples from the second year. Blood samples were collected on the same day as cognitive and physical function evaluation.
+ Open protocol
+ Expand
2

Serum Neurofilament Levels and Mortality

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum NfL levels were measured using the R-PLEX human neurofilament L antibody set (Meso Scale Discovery, F217X) in 96-well plate format. Samples were diluted 2-fold in diluent buffer and tested in duplicate according to the manufacturer's instructions. Samples from decedents and survivors were randomized across four batches in a blinded manner. The mean coefficient of variation of duplicate NfL measurements was 3.8% (0–27.5%). Vital status was determined through a National Death Index from 1/1/2000 through 12/31/2014. Deaths are coded as 1. Disease measures were based on self-report of physician-based diagnoses and included: hypertension, diabetes, cancer, COPD, heart attack, congestive heart failure, angina, asthma, arthritis, stroke, and kidney disease.
+ Open protocol
+ Expand
3

CSF Biomarker Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
We obtained 5-10 mL of CSF samples from the lumbar punctures of each study participant. Each sample was centrifuged at 4000×g for 10 min. Then, the supernatant was collected and immediately frozen in polypropylene tubes that were stored at -80 • C until assay. The biomarker assays were performed in duplicate by experienced technicians under blinded conditions, and the intra-and interassay coefficients of variation were <20%. The concentrations of Aβ42, t-tau, p-tau were measured using the Luminex xMAP platform (Luminex Corp, Austin, TX) with INNO-BIA AlzBio3 (Fujirebio Europe, Inc., Ghent, Belgium) as previously described [15] . The concentrations of NfL were measured using the R-PLEX Human Neurofilament L Antibody Set (Meso Scale Discovery, Rockville, MD). The concentrations of soluble NG2 and α-syn were measured using commercially available sandwich ELISA kits (Cloud Clone Corp. Katy, TX and Covance, Dedham, MA, respectively). We only used samples with hemoglobin (Hb) concentrations <1000 ng/mL for α-syn analysis because, as previously reported, blood contamination (Hb > 1000 ng/mL) might affect the level of CSF α-syn [4] .
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!